Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients - PubMed
- ️Sun Jan 01 2017
. 2017 Nov 27;12(11):e0188633.
doi: 10.1371/journal.pone.0188633. eCollection 2017.
Anabel García-Heredia 2 , Noemí Cabré 2 , Fedra Luciano-Mateo 2 , Anna Hernández-Aguilera 2 , Sebastià Sabater 1 , Marta Bonet 1 , Marina Gascón 1 , Salvador Fernández-Arroyo 2 , Isabel Fort-Gallifa 2 , Jordi Camps 2 , Jorge Joven 2
Affiliations
- PMID: 29176871
- PMCID: PMC5703554
- DOI: 10.1371/journal.pone.0188633
Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients
Meritxell Arenas et al. PLoS One. 2017.
Abstract
Paraoxonase-1 (PON1) is an intra-cellular antioxidant enzyme found also in the circulation associated with high-density lipoproteins. The activity of this enzyme has been shown to be decreased in breast cancer (BC) patients. The aims of our study were to investigate the changes produced by radiotherapy (RT) on activity and concentration of serum PON1 in BC patients, and to evaluate the observed variations in relation to clinical and pathological characteristics of patients and tumors, and the response to treatment. We studied 200 women with BC who were scheduled to receive RT following excision of the tumor. Blood for analyses was obtained before and after the irradiation procedure. The control group was composed of 200 healthy women. Relative to control, BC patients had significantly lower serum PON1 activities pre-RT, while PON1 concentrations were at similar levels. RT was associated with a significant increase in serum PON1 activities and concentrations. We observed significant differences in serum PON1 concentrations post-RT between patients with luminal A or luminal B tumors. Serum PON1 concentration post-RT was markedly lower in BC patients with metastases. We conclude that benefit from RT accrues to the BC patients not only through its direct effect on cancer cells but also indirectly by improving the organism's anti-oxidant defense mechanisms. In addition, our preliminary evidence suggests that the measurement of serum PON1 concentration post-RT could be an efficient prognostic biomarker, and may be used as an index of the efficacy of the RT.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures

*: P < 0.05 with respect to the wild-type isoform (QQ and LL, respectively).

AUC: Area under the curve.
Similar articles
-
Kaya MO, Sinan S, Güler ÖÖ, Arslan O. Kaya MO, et al. J Enzyme Inhib Med Chem. 2016 Dec;31(6):1349-55. doi: 10.3109/14756366.2015.1134523. Epub 2016 Jan 14. J Enzyme Inhib Med Chem. 2016. PMID: 26763308
-
Balci H, Genc H, Papila C, Can G, Papila B, Yanardag H, Uzun H. Balci H, et al. J Clin Lab Anal. 2012 May;26(3):155-60. doi: 10.1002/jcla.21503. J Clin Lab Anal. 2012. PMID: 22628230 Free PMC article.
-
Gupta N, Binukumar BK, Singh S, Sunkaria A, Kandimalla R, Bhansali A, Gill KD. Gupta N, et al. Gene. 2011 Nov 1;487(1):88-95. doi: 10.1016/j.gene.2011.07.011. Epub 2011 Jul 26. Gene. 2011. PMID: 21803130
-
Deakin SP, James RW. Deakin SP, et al. Clin Sci (Lond). 2004 Nov;107(5):435-47. doi: 10.1042/CS20040187. Clin Sci (Lond). 2004. PMID: 15265000 Review.
Cited by
-
Mekkawy MH, Fahmy HA, Nada AS, Ali OS. Mekkawy MH, et al. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420950468. doi: 10.1177/1534735420950468. Integr Cancer Ther. 2020. PMID: 32783540 Free PMC article.
-
Gabaldó X, Juanpere M, Castañé H, Rodríguez-Tomàs E, López-Azcona AF, Baiges-Gaya G, Castro L, Valverde-Díaz E, Muñoz-Blázquez A, Giménez-Cuenca L, Felipo-Balada L, Ballester F, Pujol I, Simó JM, Castro A, Iftimie S, Camps J, Joven J. Gabaldó X, et al. Biomolecules. 2022 Jun 23;12(7):879. doi: 10.3390/biom12070879. Biomolecules. 2022. PMID: 35883435 Free PMC article.
-
Santana MFM, Sawada MIBAC, Junior DRS, Giacaglia MB, Reis M, Xavier J, Côrrea-Giannella ML, Soriano FG, Gebrim LH, Ronsein GE, Passarelli M. Santana MFM, et al. Cells. 2024 Aug 9;13(16):1327. doi: 10.3390/cells13161327. Cells. 2024. PMID: 39195217 Free PMC article.
-
High density lipoproteins and oxidative stress in breast cancer.
Mazzuferi G, Bacchetti T, Islam MO, Ferretti G. Mazzuferi G, et al. Lipids Health Dis. 2021 Oct 25;20(1):143. doi: 10.1186/s12944-021-01562-1. Lipids Health Dis. 2021. PMID: 34696795 Free PMC article. Review.
-
Jasinski M, Olszewska-Slonina D. Jasinski M, et al. Antioxidants (Basel). 2022 Feb 10;11(2):346. doi: 10.3390/antiox11020346. Antioxidants (Basel). 2022. PMID: 35204228 Free PMC article.
References
-
- Simone V, D'Avenia M, Argentiero A, Felici C, Rizzo FM, De Pergola G, et al. Silvestris F. Obesity and Breast Cancer: Molecular interconnections and potential clinical applications. Oncologist. 2016; 21: 404–417. doi: 10.1634/theoncologist.2015-0351 - DOI - PMC - PubMed
-
- Kaya MO, Sinan S, Güler ÖÖ, Arslan O. Is there a relation between genetic susceptibility with cancer? A study about paraoxanase (PON1) enzyme activity in breast cancer cases. J Enzyme Inhib Med Chem. 2016; 31: 1349–1355. doi: 10.3109/14756366.2015.1134523 - DOI - PubMed
-
- Elkiran ET, Mar N, Aygen B, Gursu F, Karaoglu A, Koca S. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer. 2007; 7: 48 doi: 10.1186/1471-2407-7-48 - DOI - PMC - PubMed
-
- Barrera G. Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncol. 2012; 2012: 137289 doi: 10.5402/2012/137289 - DOI - PMC - PubMed
-
- Chander R, Kapoor NK. High-density lipoprotein is a scavenger of superoxide anions. Biochem Pharmacol. 1990; 40: 1663–1665. - PubMed
MeSH terms
Substances
Grants and funding
This work was funded by a grant from Associació Oncològica Dr. Amadeu Pelegrí, Salou, Spain, AODAP/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous